Real-time enrollment status for this diffuse large b-cell lymphoma clinical trial
Current Status
Terminated
Checked: June 2, 2026 at 3:11 AM UTC
| NCT Number | NCT05896163 |
| Recruiting Status | Terminated |
| Condition | Diffuse Large B-Cell Lymphoma |
| Phase | Clinical Trial |
| Target Enrollment | 70 participants |
| Active Locations | 11 sites in the US |
| Sponsor | Pfizer |
| Last Updated on CT.gov | May 6, 2026 (3 weeks ago) |
As of June 2, 2026: Clinical trial NCT05896163 is currently terminated participants. This clinical trial study for diffuse large b-cell lymphoma is not currently accepting new participants at 11 locations across the United States. The study is sponsored by Pfizer. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05896163 is currently terminated. The study may resume recruiting in the future.
This trial is recruiting at 11 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05896163 was last updated 3 weeks ago (May 6, 2026). HelloStudys verifies this status automatically.